General Statement of Disclosure:

CONSULTING FEES/HONORARIA: Esperion(MODEST), Abbott Diagnostic(MODEST), Roche Diagnostic(MODEST), Denka Seiken(SIGNIFICANT), New Amsterdam(MODEST), Eli Lilly and Company(SIGNIFICANT), Merck & Co., Inc.(SIGNIFICANT), Arrowhead(SIGNIFICANT), Novartis(SIGNIFICANT), Amgen(MODEST), AstraZeneca(MODEST), Ionis(MODEST), Genentech, Inc(MODEST), Illumina(MODEST), Novo Nordisk Inc.(MODEST) RESEARCH/RESEARCH GRANTS: Novartis(SIGNIFICANT), Abbott Diagnostic(SIGNIFICANT), Amgen(SIGNIFICANT), Arrowhead(SIGNIFICANT), Merck & Co., Inc.(SIGNIFICANT), Novo Nordisk Inc.(SIGNIFICANT), New Amsterdam(SIGNIFICANT), Ionis(SIGNIFICANT), Roche Diagnostic(SIGNIFICANT)

View Full Disclosure